Fri May 24 08:34:39 SGT 2013  
    Genital Warts Removal, SG / Singapore
HIV STD TESTING TREATMENT™

Notice: This is a medical information portal. This is not a clinic website.
Please go to SHIM CLINIC for the services described here.

Within 3 days after unprotected sex, stop HIV infection with Post-Exposure Prophylaxis treatment 10 days after unprotected sex, detect HIV infection with the DNA test 28 days after unprotected sex, accurately detect HIV infection with the 20 minute rapid test
Full & comprehensive sexually transmitted disease testing
Males: do not urinate for at least 4 hours before arriving
Females: testing is more accurate when you are not menstruating

Genital Warts Removal, SG / Singapore | HIV STD TESTING TREATMENT™

Summary

Genital Warts Removal, SG / Singapore | HIV STD TESTING TREATMENT™ @beauty_com.sg: Genital warts (condyloma, condylomata acuminata, venereal wart, anal wart, anogenital wart, "cauliflower" sex disease) symptoms in men/women, screening/diagnosis, testing/check, treatment clinic, SG / Singapore - Private and confidential service. Definitions, references, and latest news.

Description

Come to sunny Singapore to have your testing and treatment. Singapore Ministry of Health registered general practice (GP) clinic:

SHIM CLINIC
168 Bedok South Avenue 3 #01-473
Singapore 460168
Tel: (+65) 6100 7446
Fax: (+65) 6449 7446
24hr Answering Tel: (+65) 6333 5550
Web: Genital Warts Removal, SG / Singapore
Opening Hours
Monday to Friday: 9 am to 3 pm, 7 pm to 11 pm
Saturday & Sunday: 7 pm to 11 pm
Public Holidays: Closed
Last registration: half hour before closing time.
Walk-in clinic. Appointments not required.
Bring NRIC, Work Pass or Passport for registration.

Sexual risk (of HIV/STD/pregnancy), and what you can do before and after exposure.

Timeline Event / Available resources
HIV STD Pregnancy
Before exposure
Abstain from sex, Be faithful, or Condom use
Circumcision (males only)
Contraception
(females only)
HIV PrEP (pre-exposure prophylaxis) STD vaccine:
- Hepatitis vaccine
- HPV vaccine
STD / HIV exposure
Unsafe sex / unprotected sex:
No condom / Condom broke / Condom slip
0-72 hours HIV prevention
HIV PEP (post-exposure prophylaxis) treatment
- Stop HIV infection after exposure.
STD testing
If STD symptoms appear, then do STD treatment.
- Males: Do not urinate for at least 4 hours before arriving.
- Females: testing is more accurate when you are not menstruating.
Emergency contraception
(females only)
2 weeks HIV DNA PCR test
1 month 20 minute Alere™ Determine™ Combo HIV rapid test:
- Fingerprick blood sampling.
- Cost is SG$180/=
3 months 20 minute OraQuick® HIV rapid test:
- Oral saliva or
- Fingerprick blood sampling.
- Cost is SG$60/=
Full & comprehensive STD testing
- Males: Do not urinate for at least 4 hours before arriving.
- Females: testing is more accurate when you are not menstruating.

Note: If the clinic attendance is only for the HIV rapid test, then consultation fees are not added.

References


Latest News

Depletion of polycistronic transcripts using short interfering RNAs: cDNA synthesis method affects levels of non-targeted genes determined by quantitative PCR
Tue, 21 May 2013 04:00:00 +0100 | Virology Journal
Conclusions:

Study Explores Providers' Perceptions Of Parental Concerns About HPV Vaccination
Fri, 17 May 2013 07:00:00 +0100 | Health News from Medical News Today
A new Boston University School of Medicine (BUSM) study has found that low-income and minority parents may be more receptive to vaccinating their daughters against Human Papillomavirus (HPV), while white, middle-class parents are more likely to defer the vaccination. The findings appear online in the May issue of the Journal of Health Care for the Poor and Underserved. Cervical cancer incidence and mortality are markedly higher for low-income and minority women due to higher rates of HPV and limited access to screening and treatment... (Source: Health News from Medical News Today)

Knowledge of human papillomavirus and cervical cancer among young women recruited using a social networking site
Fri, 17 May 2013 04:00:00 +0100 | Sexually Transmitted Infections
Conclusions

Detection of high risk human papillomavirus by hybrid capture II(r) according cytological findings in women treated for squamous intraepithelial lesions of the cervix, period 2006/2010
Thu, 16 May 2013 16:10:18 +0100 | Revista Brasileira de Epidemiologia
CONCLUSION: La detección de HR-HPV por CH II(r), así como los valores de carga viral relativa altos, en especial en mujeres con NSIL podrían ayudar a identificar mujeres tratadas con riesgo a desarrollar recidivas, contribuyendo así a fortalecer el programa de prevención de cáncer de cuello uterino. OBJECTIVE: To determinate the frequency of high risk human papillomavirus (HR-HPV) by hybrid capture II (r) (CH II(r)), according cytology results in women treated for squamous intraepithelial lesions of the cervix (SIL). MATERIAL AND METHODS: A descriptive cross-sectional study of a series of cases that included 122 women treated, 79 (75%) for low grade SIL (LSIL) and 43 (35%) for high grade SIL (HSIL) attending at the HPV Laboratory at the Heal...

Human Papillomavirus, p16, and Epidermal Growth Factor Receptor Biomarkers and CT Perfusion Values in Head and Neck Squamous Cell Carcinoma [HEAD & NECK]
Wed, 15 May 2013 04:00:00 +0100 | American Journal of Neuroradiology
CONCLUSIONS:

New BUSM study explores providers' perceptions of parental concerns about HPV vaccination
Tue, 14 May 2013 04:00:00 +0100 | EurekAlert! - Social and Behavioral Science
(Boston University Medical Center) A new Boston University School of Medicine study has found that low-income and minority parents may be more receptive to vaccinating their daughters against Human Papillomavirus, while white, middle-class parents are more likely to defer the vaccination. (Source: EurekAlert! - Social and Behavioral Science)

RE: Annual Report to the Nation on the Status of Cancer, 1975-2009, Featuring the Burden and Trends in Human Papillomavirus (HPV)-Associated Cancers and HPV Vaccination Coverage Levels and RE: Inequalities in Human Papillomavirus (HPV)-Associated Cancers: Implications for the Success of HPV Vaccination
Tue, 14 May 2013 04:00:00 +0100 | JNCI
(Source: JNCI)

Transvaginal ultrasound probe contamination by the human papillomavirus in the emergency department
Mon, 13 May 2013 04:00:00 +0100 | Emergency Medicine Journal
Conclusions

College Sorority Members’ Knowledge and Behaviors Regarding Human Papillomavirus and Cervical Cancer
Sat, 11 May 2013 00:18:46 +0100 | Nursing Clinics of North America
This study describes female college students’ knowledge regarding HPV and cervical cancer, identifies sexual risk behaviors in this group, and assesses whether there is any relationship between knowledge of HPV and cervical cancer and the sexual risk behaviors in this population. Health care providers need to be aware of this health issue and actively promote appropriate prevention strategies. (Source: Nursing Clinics of North America)

Africa: Merck's HPV Vaccine Available in Africa Through Unicef Tender
Fri, 10 May 2013 15:30:21 +0100 | AllAfrica News: Health and Medicine
[Merck]LUCERNE, Switzerland, May 9, 2013 -MSD, known as Merck in the United States and Canada, announced today that the company has been awarded a significant portion of the UNICEF human papillomavirus (HPV) vaccine tender, and will provide sustained supply of GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant] to GAVI-eligible countries. This agreement follows the GAVI Alliance's earlier announcement that HPV vaccines would be included in its po (Source: AllAfrica News: Health and Medicine)